Finance

Lists
Why is EDIT down 3,39%?
Dive Deeper
EDIT:NASDAQ
Editas Medicine Inc
US$1,71
-3,39%
(-0,060) 1D
US$1,70
-0,58% (-0,0100)
Pre-market
Closed: 19 ພ.ຈ., 16 ໂມງ 0 ນາທີ 01 ວິນາທີ GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for EDIT...
Open
US$1,80
High
US$1,83
Low
US$1,70
Mkt. cap
263,92 ລ້ານ
Avg. vol.
2,38 ລ້ານ
Volume
1,14 ພັນ
52-wk high
US$3,94
52-wk low
US$1,66
EPS
US$-0,62
Beta
2,09
Shares outstanding
154,34 ລ້ານ
No. of employees
87
Open
US$1,80
High
US$1,83
Low
US$1,70
Mkt. cap
263,92 ລ້ານ
Avg. vol.
2,38 ລ້ານ
Volume
1,14 ພັນ
52-wk high
US$3,94
52-wk low
US$1,66
EPS
US$-0,62
Beta
2,09
Shares outstanding
154,34 ລ້ານ
No. of employees
87
News stories
From web sources and news partners
Adam Feldman | Substack
Adam Feldman | Substack
·
18 ຊົ່ວໂມງກ່ອນ
Inside the Federal Litigation of Five S&P 500 Giants
RealMoney Pro
RealMoney Pro
·
13 ຊົ່ວໂມງກ່ອນ
Anthropic Pops, but the S&P 500 Drops
Trefis
Trefis
·
5 ຊົ່ວໂມງກ່ອນ
S&P 500 Movers | Winners: PANW, OKTA, P | Losers: WSM, TWLO, AMD
The Harvard Law School Forum on Corporate Governance
The Harvard Law School Forum on Corporate Governance
·
23 ຊົ່ວໂມງກ່ອນ
Board Practices and Composition in the Russell 3000 and S&P 500
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc
CEO-
Employees87
Foundedພ.ຈ. 2013
Headquarters-
SectorHealth Care
IndustryBiotechnology
Analyst ratings
Based on 4 analysts giving stock ratings to EDIT in the past 3 months
Strong buy
Buy
3
Hold
1
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for EDIT in the last 3 months.
Highest
Current US$1,71
US$6,00 (+250,88%)
Average
US$5,00 (+192,40%)
Lowest
US$4,00 (+133,92%)
Analyst
Recommendation
Action
Price target
Projected
Date
Mitchell Kapoor
H.C. Wainwright
Buy
Reiterated
US$5,00
+192,4%
11/10/2026
Luca Issi
RBC Capital
Hold
Maintained
US$4,00
+133,9%
11/09/2026
Yanan Zhu
Wells Fargo
Buy
Maintained
US$6,00
+250,9%
11/09/2026
Debjit Chattopadhyay
Guggenheim
Buy
Upgraded
US$5,00
+192,4%
09/23/2026
Rick Bienkowski
Ladenburg Thalmann & Co.
Buy
Initiated
US$6,00
+250,9%
08/18/2026
Alec Stranahan
Bank of America Securities
Sell
Reiterated
-
-
08/07/2026
Phil Nadeau
TD Cowen
Buy
Maintained
-
-
08/05/2026
Boris Peaker
JonesTrading
Buy
Maintained
US$8,00
+367,8%
08/05/2026
Jonathan Miller
Evercore ISI
Buy
Maintained
US$15,00
+777,2%
05/27/2026
Geulah Livshits
Chardan Capital
Buy
Reiterated
US$4,00
+133,9%
05/05/2026
Soumit Roy
JonesTrading
Buy
Maintained
US$8,00
+367,8%
04/06/2026
Joon Lee
Truist Financial
Hold
Maintained
-
-
03/17/2026
Brian Cheng
J.P. Morgan
Sell
Maintained
-
-
03/13/2026
William Maughan
Clear Street
Buy
Maintained
US$4,60
+169%
03/10/2026
Last report
9 ພ.ຈ. 2026
Fiscal period
Q3 2026
US$-0,15 / US$-0,21
+27,23%beat
Revenue / Est. (USD)
10,36 ລ້ານ / 4,46 ລ້ານ
+132,42%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
ກ.ຍ. 2026
Revenue
24,74 ລ້ານ
2,83 ລ້ານ
11,89 ລ້ານ
10,36 ລ້ານ
Cost of goods sold
27,40 ລ້ານ
17,60 ລ້ານ
20,18 ລ້ານ
21,17 ລ້ານ
Cost of revenue
27,40 ລ້ານ
17,60 ລ້ານ
20,18 ລ້ານ
21,17 ລ້ານ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11,35 ລ້ານ
10,23 ລ້ານ
11,60 ລ້ານ
13,48 ລ້ານ
Operating expense
11,35 ລ້ານ
10,23 ລ້ານ
11,60 ລ້ານ
13,48 ລ້ານ
Total operating expenses
38,76 ລ້ານ
27,83 ລ້ານ
31,78 ລ້ານ
34,65 ລ້ານ
Operating income
-14,02 ລ້ານ
-25,00 ລ້ານ
-19,89 ລ້ານ
-24,28 ລ້ານ
Other non operating income
2,18 ລ້ານ
-113,00 ພັນ
17,00 ພັນ
-1,00 ພັນ
EBT including unusual items
-5,62 ລ້ານ
-24,98 ລ້ານ
-18,23 ລ້ານ
-23,39 ລ້ານ
EBT excluding unusual items
-9,69 ລ້ານ
-24,98 ລ້ານ
-19,57 ລ້ານ
-23,39 ລ້ານ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-5,62 ລ້ານ
-24,98 ລ້ານ
-18,23 ລ້ານ
-23,39 ລ້ານ
Net profit margin
-22,72%
-882,44%
-153,32%
-225,69%
Earnings per share
-0,06
-0,26
-0,15
-0,15
Interest and investment income
2,14 ລ້ານ
1,21 ລ້ານ
1,37 ລ້ານ
1,97 ລ້ານ
Interest expense
-
-1,07 ລ້ານ
-1,06 ລ້ານ
-1,08 ລ້ານ
Net interest expenses
2,14 ລ້ານ
134,00 ພັນ
307,00 ພັນ
890,00 ພັນ
Depreciation and amortization charges
-
-
-
-
EBITDA
-13,21 ລ້ານ
-24,52 ລ້ານ
-19,48 ລ້ານ
-23,90 ລ້ານ
Gain or loss from assets sale
34,00 ພັນ
-
111,00 ພັນ
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
ແອັບຂອງ Google